The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls

Rheumatology International

Volumn 32, Issue 4, 2012, Pages 991-995

  Heidari, Behzad ^a   Hajian Tilaki, Karimollah ^a   Heidari, Parnaz ^b  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Association; Rheumatoid arthritis; Undifferentiated inflammatory arthritis; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANK SUM TEST; RHEUMATOID ARTHRITIS; RISK; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNDIFFERENTIATED INFLAMMATORY ARTHRITIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; ARTHRITIS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84861219063     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1736-3     Document Type: Article

References (34)

1. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353-373 (Pubitemid 43334631)
2. Gannagé-Yared MH, Tohmé A, Halaby G (2001) Hypovitaminosis D: a major worldwide public health problem. Presse Med 7(30):653-658 (Pubitemid 32416679)
3. Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endocrinol Metab 95:471-478
4. Cutulo M, Otsa K, Paolino S, Yrrus M, Veldi T, Seriolo B (2008) Vitamin D involvement in rheumatoid arthritis and systemic lupus erythgmatosus. Ann Rheum Dis 67:530-535
5. Pérez-López FR (2007) Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 58(2):117-137 (Epub 2007 Jun 29) (Pubitemid 47503630)
6. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis 66:1137-1142 (Pubitemid 47309727)
7. Ranganathan P (2009) Genetics of bone loss in rheumatoid arthritis-role of vitamin D receptor polymorphisms. Rheumatology (Oxford) 48(4):342-346
8. Tetlove LC, Wolley DE (1999) The effect of 1 alpha 25-dihydroxyvitamin D3 on matrixmetalloproteinase and prostgalndin E2 production by cells of rheumatoid lesion. Arthritis Res 1:63-70
9. Albert PJ, Proal AD, Marshall TG (2009) Vitamin D: the alternative hypothesis. Autoimmun Rev 8(8):639-644
10. Szodoray P, Nakken B, Gaal J et al (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68(3): 261-269
11. Deluca HF, Cantorna MT (2001) Vitamin D: it's role and uses in immunology. FASEB J 15:2579-2585 (Pubitemid 33131084)
12. Kamen DL, Aranow C (2008) The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 10:273-280
13. Alele JD, Kamen DL (2010) The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun Rev 9(3):137-139
14. Cutolo M, Otsa K (2008) Review: vitamin D, immunity and lupus. Lupus 17(1):6-10
15. Zold E, Szodoray P, Kappelmayer J et al (2008) Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 10:R123
16. Damanhouri LH (2009) Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 30:1291-1295
17. Turhanoǧlu AD, Güler H, Yönden Z, Aslan F, Mansuroglu A, Ozer C (2010) The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int. doi:10.1007/s00296-010-1393-6
18. Craig SM, Yu F, Curtis JR et al (2010) Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. Rheumatol 37(2): 275-281
19. Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir AM, Balbir-Gurman A (2009) Vitamin D level: is it related to disease activity in inflammatory joint disease? Rheumatol Int. doi:10.1007/s00296-009-1251-6
20. Patel S, Farrager T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolites levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143-2149 (Pubitemid 47173561)
21. Arnett FC, Edworthy SN, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324 (Pubitemid 18091653)
22. Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X (2009) Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Res Ther 11:R114
23. Heidari B, Firouzjahi A, Heidari P, Hajian K (2009) The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis. Ann Saudi Med 29(6):467-470
24. Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmune Rev 9:140-143
25. Caro-Oleas JL, Fernandez-Suarez A, Reneses CS, Porrino C, Nunez-Roldan A, Wichman SI (2008) Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow- up. Clin Exp Rheumatol 26:461-463 (Pubitemid 352003217)
26. Vaz CC, Couto M, Medeiros D et al (2009) Undifferentiated connective tissue disease: a seven-center cross-sectional a study of 184 patients. Clin Rheumatol 28:915-921
27. Kudo-Tanaka E, Ohshima S, Ishi M (2007) Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clin Rheumatol 26:1627-1633
28. Emery P, Durez P, Dougados M et al (2010) Impact of T cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis 69:510-516
29. Jeffery LE, Burke F, Mura M et al (2009) 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and Fox3. J Immunol 183:5458-5467
30. Cutolo M (2009) Vitamin D and autoimmune rheumatic disease. Rheumatology 48:210-212
31. Andjelkovic Z, Voojinivic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453-456 (Pubitemid 29343630)
32. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. (2010) Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity an damage. Arthritis Care Res (Hoboken) [Epub ahead of print]. doi: 10.1002/acr.20186
33. Gaal J, Lakos G, Szodoray P et al (2009) Immunological and clinical effects of alphacalcidiol in patients with psoriatic arthropathy: results of an open, follow-up pilot study. Acta Derm Venerol 89:140-144
34. Gouch A, Sambrook P, Delvin J et al (1998) Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol 25:864-868 (Pubitemid 28210545)